Share
Host Cell Protein Testing Market Size, Share, and Analysis, By Testing Type (PCR-Based Assays, ELISA-Based Assays, Mass Spectrometry-Based Assays, Others), By End User (Contract Research Organizations, Biopharmaceutical Companies, Others) and Regional Forecasts, 2022-2032
Host Cell Protein Testing Market size was USD 0.94 billion in 2021 and projected to grow from USD 1.0 billion in 2023 to USD 1.7 billion by 2032, exhibiting a CAGR of 5.7% during the forecast period.
Host Cell Proteins or HCPs are the process-associated protein contamination that are developed by the host bacterium in the course of biotherapeutic production and manufacturing. Most of the developed HCPs are eliminated from the finished product during the purification process (more than 99 percent impurities eliminated). HCP analysis is a technique to determine how much host cell protein is present in samples from drug material and downstream purification.
Host Cell Protein Testing Market is expected to reach USD 1.7 billion, growing at a CAGR of 5.7% during the forecast period owing to the rising demand for biopharmaceuticals. Moreover, the improvements in the biopharmaceutical domain as well as expanding R&D activities are expected to boost the growth of Host Cell Protein Testing Market over the forecast period.
Host Cell Protein Testing Market is classified based on the Testing Type into PCR-Based Assays, ELISA-Based Assays, Mass Spectrometry-Based Assays, and Others. The PCR-Based Assays segment dominated the market in the past years. Genetic material from a particular organism, including a virus, can be found using PCR-based techniques. These tests are generally used for the quick and accurate detection of infectious diseases including those brought on by viruses or bacteria. Anaerobic microorganisms, for example, are used to identify non-cultivable or slowly growing bacteria. However, the mass spectrometry-based assays category will be holding the largest rate of growth during the projection period. The growing prevalence of chronic diseases, as well as increased R&D funding for manufacturing novel diagnostic processes are projected to fuel segment growth.
Host Cell Protein Testing Market is classified based on the End User into Contract Research Organizations, Biopharmaceutical Companies, Others. The Biopharmaceutical Companies category led the market in the previous years. This is attributed to the increased use of HCP testing in biopharmaceutical businesses. Biopharmaceutical medications are used to treat a wide range of disorders, including diabetes, cardiovascular disease, and cancer. Contract Research Organizations, on the other hand, is the fastest-growing sector, owing to the increased government financing for research operations.
Growing Demand for Drugs Needed for Different Cancer Types and Ongoing R&D Activities are Expected to Boost the Market Growth
The increasing demand for medications to treat different cancer types and inflammatory ailments has compelled market participants to upgrade biopharmaceutical research centers and manufacturing units. Such demand is stimulating the growth of biopharmaceutical capabilities, which increased the volume of medication production even further. Furthermore, continued testing-related research and development activities, as well as an increasing number of governing approvals for testing equipment, will drive market growth.
Remarkable Technical Advancements are expected to Boost the Market Growth
The remarkable technical advancements in HCP testing equipment, with a great emphasis on uplifting their superiority and incorporating more features, would be beneficial to the global market. To acquire a larger saturation in the Host Cell Protein Testing Market, most suppliers are focusing on product and technological developments as well as acquiring clearance from authoritative bodies. These factors are projected to fuel the Host Cell Protein Testing Market in future.
Growing Concerns Related to Immunogenesis is expected to Restrain the Market Growth
Concerns associated with immunogenesis is one of the major restraining factors of the Host Cell Protein Testing Market. Furthermore, issues with the accuracy and efficiency of the test kits, as well as long-term returns among consumers, may limit market expansion.
Host Cell Protein Testing Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America is expected to registered a major share of the host cell protein testing market due to increased R&D investments, the presence of significant businesses, and the region's matured healthcare infrastructure. Europe is expected to account for a large part of the market due to supportive government initiatives and increased R&D spending. Asia-Pacific is expected to be the quickest-growing market throughout the projection period owing to the high prevalence of chronic diseases like cancer and expanding economies.
The global spread of the lethal corona virus impeded commodity mobility across regions and continents. The virus outbreak had an effect on the overalls supply chain, starting from delivery of raw material to final goods transportation. A specific team of suppliers was organized to analyze the whole raw materials and finished products supply chain. During the epidemic, the special group was in charge of evaluating cross-border issues and trade limitations. Furthermore, in order to meet the standards, the manufacturers updated their transportation and packaging infrastructure.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2022-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 5.7% from 2022-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
Testing Type |
|
|
End User |
|
|
By Region |
|
Host Cell Protein Testing Market size was estimated at USD 0.94 billion in 2021 and is expected to reach USD 1.7 billion in 2032.
Host Cell Proteins or HCPs are the process-associated protein contamination that are developed by the host bacterium in the course of biotherapeutic production and manufacturing.
Mass Spectrometry-Based Assays and Contract Research Organizations segments accounted for the largest Host Cell Protein Testing Market share.
Key players: Thermo Fisher Scientific Inc., Charles River Laboratories International Inc., Agilent, PerkinElmer, Sartorius AG, Pall Corporation, Bio-Rad Laboratories Inc., Abcam Plc, Enzo Life Sciences Inc., Cygnus Technologies LLC, Rockland Immunochemicals Inc., Cisbio Bioassays, Prolytix, Biogenes Gmbh, Creative Proteomics, and Other Prominent Players are the key players in the Host Cell Protein Testing Market.
The rising demand for medications to treat various forms of cancer and inflammatory disorders, which forced market participants to upgrade their biopharmaceutical production facilities and research along with biopharmaceutical improvements with growing R&D activity are driving the Host Cell Protein Testing Market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
